| Page | |
|---|---|
| Balance Sheet | 1—2 |
| Notes to the Financial Statements | 3—5 |
| 2024 | 2023 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ | £ | £ | |
| FIXED ASSETS | |||||
| Intangible Assets | 4 |
|
|
||
| Tangible Assets | 5 |
|
|
||
|
|
|
||||
| CURRENT ASSETS | |||||
| Stocks | 6 |
|
|
||
| Debtors | 7 |
|
|
||
| Cash at bank and in hand |
|
|
|||
|
|
|
||||
| Creditors: Amounts Falling Due Within One Year | 8 |
( |
( |
||
| NET CURRENT ASSETS (LIABILITIES) |
( |
( |
|||
| TOTAL ASSETS LESS CURRENT LIABILITIES |
( |
( |
|||
| PROVISIONS FOR LIABILITIES | |||||
| Deferred Taxation |
( |
( |
|||
| NET LIABILITIES |
( |
( |
|||
| CAPITAL AND RESERVES | |||||
| Called up share capital | 9 |
|
|
||
| Profit and Loss Account |
( |
( |
|||
| SHAREHOLDERS' FUNDS | (216,648) | (164,189) | |||
|
Director
|
Director
|
|
|
| Fixtures & Fittings |
|
| Computer Equipment |
|
| Goodwill | |||
|---|---|---|---|
| £ | |||
| Cost | |||
| As at 1 November 2023 |
|
||
| As at 31 October 2024 |
|
||
| Amortisation | |||
| As at 1 November 2023 |
|
||
| Provided during the period |
|
||
| As at 31 October 2024 |
|
||
| Net Book Value | |||
| As at 31 October 2024 |
|
||
| As at 1 November 2023 |
|
||
| Fixtures & Fittings | Computer Equipment | Total | |
|---|---|---|---|
| £ | £ | £ | |
| Cost | |||
| As at 1 November 2023 |
|
|
|
| As at 31 October 2024 |
|
|
|
| Depreciation | |||
| As at 1 November 2023 |
|
|
|
| Provided during the period |
|
|
|
| As at 31 October 2024 |
|
|
|
| Net Book Value | |||
| As at 31 October 2024 |
|
|
|
| As at 1 November 2023 |
|
|
|
| 2024 | 2023 | ||
|---|---|---|---|
| £ | £ | ||
| Finished goods |
|
|
|
| 2024 | 2023 | ||
|---|---|---|---|
| £ | £ | ||
| Due within one year | |||
| Trade debtors |
|
|
|
| Prepayments and accrued income |
|
|
|
| Other debtors |
|
|
|
| VAT |
|
|
|
| Other taxes and social security |
|
- | |
|
|
|
||
| 2024 | 2023 | ||
|---|---|---|---|
| £ | £ | ||
| Trade creditors |
|
|
|
| Bank loans and overdrafts |
|
|
|
| Other taxes and social security | - |
|
|
| Other creditors |
|
|
|
| Accruals and deferred income |
|
|
|
| Directors' loan accounts |
|
|
|
| Amounts owed to group undertakings |
|
|
|
|
|
|
||
Gidi Solutions Limited
Shares a director with Fountain RX Limited
As at the balance sheet date, the amount due to Gidi Solutions Limited was £2,275 (2023: £2,275). There are no fixed repayment terms and no interest is charged on the loan.
MidRX Group Limited
Shares a director with Fountain RX Limited
As at the balance sheet date, the amount owed by MidRX Group Limited £34,729 (2023: £nil). There are no fixed repayment terms and no interest is charged on the loan.
Saxel Limited
Shares a director with Fountain RX Limited
As at the balance sheet date, the amount due to Saxel Limited £4,886 (2023: £nil). There are no fixed repayment terms and no interest is charged on the loan.
SA2 Limited
Shares a director with Fountain RX Limited
As at the balance sheet date, the amount due to SA2 Limited was £67,989 (2023: £127,352). There are no fixed repayment terms and no interest is charged on the loan.